Yoel Bakas discusses his focus on the conversations at ACRO and the challenges in healthcare administration, including capital plans, AI investments, and margin pressure.

Takeaways

• ACRO conversations
• Challenges in healthcare administration

The conversation delves into the multifaceted nature of margin target challenges in oncology programs, highlighting the various factors that contribute to missed targets. It also emphasizes the importance of recognizing that growth failure is often a result of execution issues rather than the failure of the growth strategy.

Takeaways

• Multiple factors contribute to missed margin targets in oncology programs.
• Growth failure is often a result of execution issues, not the failure of the growth strategy.

The conversation delves into the impact of the reimbursement change on capital plans and the hidden strategy gap in growth plans. It also explores the need for a sanity check in response to the changing landscape of healthcare delivery.

Takeaways

• Reimbursement change impact
• Hidden strategy gap

Yoel Bakas has spent 20 years in the medtech industry, focusing on structuring complex medtech deals and ensuring technology investments are mathematically successful. He shares a success story of unlocking $3 million in capital savings for a client and emphasizes the importance of preserving vendor relationships while ensuring hospital solvency. He expresses gratitude to his network and invites introductions for those navigating clinical ambition and financial pressure. The next chapter for Medsolve Dynamics is just beginning.

Takeaways

• Medtech deal structuring
• Closing the gap between ROI and P&L
• Preserving vendor relationships